CYSB2400237 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-09-13 | | Zhuhai United Laboratories Co Ltd | | | view |
CYSB2400236 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-09-13 | | Zhuhai United Laboratories Co Ltd | | | view |
JYSZ2400051 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | License Renew | 2024-09-04 | | | | | view |
CYSB2400224 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-08-29 | | Gan & Lee Pharmaceuticals | | | view |
CYSB2400146 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(3.3) | Supplementary Application | 2024-06-06 | | Yichang HEC Changjiang Pharmaceutical Co Ltd | | | view |
CYSB2400140 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-06-01 | | Gan & Lee Pharmaceuticals | | | view |
CYSB2400141 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-06-01 | | Gan & Lee Pharmaceuticals | | | view |
CYSB2400113 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(3.3) | Supplementary Application | 2024-05-14 | | Wanbang Biopharmaceuticals | | | view |
JYSB2400080 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-04-08 | | | | | view |
JYSB2400079 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-04-08 | | | | | view |
CYSB2400040 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-02-09 | | Gan & Lee Pharmaceuticals | | | view |
CYSB2400041 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-02-09 | | Gan & Lee Pharmaceuticals | | | view |
CYSB2300211 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2023-11-22 | | Sanofi (Beijing) Pharmaceuticals Co Ltd | | | view |
CYSB2300212 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2023-11-22 | | Sanofi (Beijing) Pharmaceuticals Co Ltd | | | view |
CYSB2300190 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(3.3) | Supplementary Application | 2023-10-26 | | Wanbang Biopharmaceuticals | | | view |
CYSB2300082 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(3.4) | Supplementary Application | 2023-04-13 | | Shandong New Time Pharmaceutical Co Ltd | | | view |
CYSB2300078 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2023-04-05 | | Gan & Lee Pharmaceuticals | | | view |
CYSB2300079 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2023-04-05 | | Gan & Lee Pharmaceuticals | | | view |
JYSZ2300012 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | License Renew | 2023-02-28 | | | | | view |
JYSZ2300013 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | License Renew | 2023-02-28 | | | | | view |